Citigroup Inc Pds Biotechnology Corp Transaction History
Citigroup Inc
- $169 Billion
- Q3 2024
A detailed history of Citigroup Inc transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Citigroup Inc holds 22 shares of PDSB stock, worth $32. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22
Previous 23,503
99.91%
Holding current value
$32
Previous $68,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding PDSB
# of Institutions
65Shares Held
4.05MCall Options Held
253KPut Options Held
70.4K-
Vanguard Group Inc Valley Forge, PA1.52MShares$2.22 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$710,9710.0% of portfolio
-
Geode Capital Management, LLC Boston, MA415KShares$606,0640.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny234KShares$341,9450.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA134KShares$196,0190.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $41.5M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...